BioSpace News Archive

Relmada Therapeutics, Inc., a late-stage biotechnology company addressing diseases of the central nervous system, announced the publication of Phase 2 data from the clinical study of REL-1017 as adjunctive treatment for patients with major depressive disorder in the peer-reviewed American Journal of Psychiatry, the most widely read psychiatric journal in the world.

Petros Pharmaceuticals, Inc. today announced that it has entered into definitive agreements with the company’s largest investor and other existing investors, for the purchase and sale of 2,186,589 shares of Petros Pharmaceuticals’ common stock, at a purchase price of $3.43 per share.

Linepharma International Ltd. announced today that its subsidiary Linepharma KK has applied for manufacturing and marketing approval in Japan for its oral drug MEFEEGO™ for the medical termination of pregnancies of up to 63 days of gestation.

Phase 1 program supports plan to start clinical trials in H2 2022 for NervGen’s NVG-291 in spinal cord injury, multiple sclerosis and Alzheimer’s disease indications.

Medtronic plc, a global leader in healthcare technology, announced that the U.S. Centers for Medicare & Medicaid Services will expand Medicare coverage for all types of continuous glucose monitors, including adjunctive and non-adjunctive CGMs.

According to Emergen Research, the global bioanalytical testing services market size was USD 1.80 Billion in 2020 and is expected to reach USD 4.33 Billion in 2028 and register a revenue CAGR of 11.5% during the forecast period, 2021-2028.

According to Emergen Research, the global nanotechnology market size was USD 75.80 Billion in 2020 and is expected to reach USD 290.93 Billion in 2028 and register a revenue CAGR of 18.3% during the forecast period, 2021-2028.

The industry analysis report is considered a valuable source of information about the global Medical Stethoscopes industry and lays stress on the future market scope, emerging industry trends, industry statistics, and market growth potential during the forecast years.

Timothy B. Niewold Will help lead the nation’s largest staff of Rheumatologists to advance basic and translational research in rheumatic and musculoskeletal diseases.

UpScript Health today announced that it has named George Jones as Chief Operating Officer (COO).